Awen Gallimore on Muck Rack

Awen Gallimore

As seen in: Immunology journal, Color Research & Application, Nature, Wales Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Awen

Contact Awen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The link between T cell activation and development of functionally useful tumour-associated high endothelial venules

|
By Stefan Milutinovic, Awen Gallimore
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (599) Issue with article?

Cardiff University Cancer Symposium 2023: a showcase of innovative new research by our early career researchers

|
By Helen Pearson, Awen Gallimore, Sarah N. Lauder, Daniel J Turnham
| Cardiff University
Prizes were also awarded for the best research posters with 1st place going to Carwyn Hughes for his poster on developing nanobodies for targeting HER2+ breast cancers, 2nd place to Maryam Alanazi who used bioinformatic approaches to look at the role of nuclear ribonucleoproteins in acute myeloid leukaemia and 3rd to Rebecca Wallace who described the development of novel oncolytic viruses.
Open in Who Shared Issue with article?

Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach

|
By Sarah N. Lauder, Bart Vanhaesebroeck, Awen Gallimore, Paul O’Gorman Building
| Nature Verified
Summary Emerging studies have demonstrated the potential of PI3Kδ blockade as an immunotherapy for solid tumours. In pre-clinical models, we recently demonstrated that anti-LAG3 immune checkpoint blockade vastly potentiated PI3Kδ-based immunotherapy, enabling successful tumour control in all treated mice.
Open in Who Shared Issue with article?
See all 6 licensed articles (7 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified